Nobilis® Salenvac ETC suspension for injection for chickens
Nobilis Salenvac ETC is an extension of the Nobilis Salenvac T vaccine by adding C-group Salmonella control.
Nobilis Salenvac ETC offers broad-spectrum control against the three main identified species of Salmonella: Salmonella Enteritidis PT4, Salmonella Typhimurium DT 104, Salmonella Infantis. Studies show that Salenvac ETC also offers cross protection against Salmonella species not found in the vaccine including: Salmonella Hadar, Salmonella Heidelberg, Salmonella Virchow.
Presentation
A homogeneous, cream to mid-brown suspension for injection.
Active ingredients
Each dose of 0.5 ml contains:
Inactivated Salmonella Enteritidis, strain PT4: 1 – 6.6 RP*
Inactivated Salmonella Typhimurium, strain DT104: 1 – 16.1 RP
Inactivated Salmonella Infantis, strain A, S03499-06: 1 – 26.6 RP
*RP (relative potency): Ratio of antigenic mass (in Units) as compared to the antigenic mass (in Units) of a reference batch which was shown to be efficacious in chickens.
Target species
Chickens
Indications for use
For the active immunisation of chickens from 6 weeks of age to reduce colonisation and faecal excretion of S. Enteritidis (serogroup D), S. Typhimurium and S. Heidelberg (serogroup B), S. Infantis, S. Hadar and S. Virchow (serogroup C).
Onset of immunity after the second vaccination
− S. Enteritidis, S. Typhimurium, S. Infantis, S. Hadar and S. Virchow: 4 weeks
− S. Heidelberg: 9 weeks*
*Earliest timepoint investigated
Duration of immunity after the second vaccination
− S. Enteritidis: 48 weeks (evidenced by challenge) and 90 weeks (evidenced by serology)
− S. Typhimurium: 57 weeks (evidenced by challenge) and 90 weeks (evidenced by serology)
− S. Infantis: 51 weeks (evidenced by challenge)
− S. Hadar: 51 weeks (evidenced by challenge)
− S. Virchow: 51 weeks (drawn from scientific reasoning)
− S. Heidelberg: 57 weeks (drawn from scientific reasoning)
Withdrawal periods
Poultry - meat 0 days, eggs 0 days
Packaging
Cardboard carton containing low density polyethylene bottle 500 ml (1000 doses) with a halogenobutyl stopper and sealed with an aluminium cap.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: April 2024
